Protai Company
Protai empowers drug discovery with proteomics and artificial intelligence to unlock new layers of biological insights and to combat complex diseases. Protai's platform has made a leap in solving how drug candidates are created and validated, facilitating quicker and more advanced drug discovery.
Founded Date:
2021-01-01
Last Funding Date:
2023-03-15
Industry:
Quantum Chemistry
Total Funding:
20000000
Headquarters:
Tel Aviv,Tel Aviv,Israel,Asia
Employee Number:
11-50
Funding Status:
private
Super Industry:
Quantum Science Applications
Funding Stage:
Seed
Funding Total Value:
20000000
Last Funding Total Usd:
12000000
Last Funding Total Currency:
USD
Last Funding Total Value:
12000000
Founders:
Eran Seger,Kirill Pevzner